Association of tumor infiltrating lymphocyte quantity with survival in patients (pts) with metastatic breast cancer (MBC) receiving microtubule-targeting agents: Post hoc analysis CALGB 40502 (Alliance).
- Citation:
- J Clin Oncol vol 41 (suppl 16) 1010
- Meeting Instance:
- ASCO 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Published Only
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 4154
- Pharmas:
- BMS, Celgene
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Daniel G. Stover Roberto Salgado Oleksander Savenkov Karla Ballman Mark Magbanua Sherene Loi Erica L. Mayer Mark Vater Kristyn Glover Mark Watson Yujia Wen W. Fraser Symmans Charles Perou Lisa Carey Ann Partridge Hope S. Rugo
- Networks:
- CA136, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-OH007, LAPS-TX035
- Study
- CALGB-40502
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: